These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10354547)

  • 1. Immune correlates of protection from HIV and AIDS - more answers but yet more questions.
    Heeney JL; Beverley P; McMichael A; Shearer G; Strominger J; Wahren B; Weber J; Gotch F
    Immunol Today; 1999 Jun; 20(6):247-51. PubMed ID: 10354547
    [No Abstract]   [Full Text] [Related]  

  • 2. An immuno-logic hypothesis.
    Kohler H; Muller S
    J Med Primatol; 2002 Aug; 31(4-5):311-2. PubMed ID: 12390548
    [No Abstract]   [Full Text] [Related]  

  • 3. Alternative HIV vaccine strategies.
    Lehner T; Shearer GM
    Science; 2002 Aug; 297(5585):1276-7. PubMed ID: 12194176
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDS vaccines: is older better?
    Cohen J
    Science; 1992 Dec; 258(5090):1880-1. PubMed ID: 1470911
    [No Abstract]   [Full Text] [Related]  

  • 6. Live-attenuated HIV vaccines: how safe is safe enough?
    Murphey-Corb M
    Nat Med; 1997 Jan; 3(1):17-8. PubMed ID: 8986728
    [No Abstract]   [Full Text] [Related]  

  • 7. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.
    Rose NF; Marx PA; Luckay A; Nixon DF; Moretto WJ; Donahoe SM; Montefiori D; Roberts A; Buonocore L; Rose JK
    Cell; 2001 Sep; 106(5):539-49. PubMed ID: 11551502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS response.
    Nature; 1991 Dec; 354(6353):439-40. PubMed ID: 1684222
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of an AIDS vaccine: a daunting epidemiological challenge.
    Nathanson N; Mathieson BJ
    Eur J Epidemiol; 2005; 20(2):123-6. PubMed ID: 15792276
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunization for long-term protection against AIDS using the macaque model.
    Kumar A; Narayan O
    Virology; 2001 Jun; 285(1):1-5. PubMed ID: 11414799
    [No Abstract]   [Full Text] [Related]  

  • 11. AIDS. Escape from the immune system.
    Walker BD; Goulder PJ
    Nature; 2000 Sep; 407(6802):313-4. PubMed ID: 11014174
    [No Abstract]   [Full Text] [Related]  

  • 12. 25 years of HIV research! ... and what about a vaccine?
    Appay V
    Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines. Monkey puzzles.
    Cohen J
    Science; 2002 Jun; 296(5577):2325-6. PubMed ID: 12089425
    [No Abstract]   [Full Text] [Related]  

  • 14. The primate connection.
    Trivedi B
    Nature; 2010 Jul; 466(7304):S5. PubMed ID: 20631704
    [No Abstract]   [Full Text] [Related]  

  • 15. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine.
    Igarashi T; Ami Y; Yamamoto H; Shibata R; Kuwata T; Mukai R; Shinohara K; Komatsu T; Adachi A; Hayami M
    J Gen Virol; 1997 May; 78 ( Pt 5)():985-9. PubMed ID: 9152414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS vaccines. Long-lasting immunity conferred in monkeys.
    Cohen J
    Science; 2001 Mar; 291(5510):1879-81. PubMed ID: 11245180
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of protection of live attenuated simian immunodeficiency virus: coevolution of viral and immune responses.
    Cohen GB
    AIDS; 2010 Mar; 24(5):637-48. PubMed ID: 20186034
    [No Abstract]   [Full Text] [Related]  

  • 18. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV vaccine design: insights from live attenuated SIV vaccines.
    Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
    Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. India targets local HIV strain in test of AIDS vaccine.
    Jayaraman KS
    Nature; 2004 Jan; 427(6971):185. PubMed ID: 14724601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.